Profiel

Founder of Gilead Sciences, Inc., Forty Seven, Inc., Hepatx Corp.
and TenSixteen Bio, Inc., Mark Chao is an entrepreneur who holds the position of Chief Executive Officer at TenSixteen Bio, Inc., Scientific Advisory Board Member at IconOVir Bio, Inc., Scientific Advisory Board Member at TigaTx, Inc., Senior Vice President & Head-Clinical Development at Forty Seven, Inc., Venture Partner at Foresite Labs LLC and Advisor at Bioverge Funds Management LLC.
In his past career he held the position of Senior Vice President-Clinical Development at Gilead Sciences, Inc. Dr. Chao received an undergraduate degree from Case Western Reserve University, a graduate degree and a doctorate from Stanford University School of Medicine and a graduate degree from Stanford University.

Actieve functies van Mark Chao

BedrijvenFunctieBegin
FORTY SEVEN, INC. Founder 01-01-2014
Founder 01-01-2015
Chief Executive Officer 01-01-2021
Foresite Labs LLC Private Equity Investor 01-01-2021
Consultant / Advisor 01-12-2021
Consultant / Advisor 01-05-2020
Consultant / Advisor -
Alle actieve functies van Mark Chao

Eerdere bekende functies van Mark Chao

Opleiding van Mark Chao

Stanford University Graduate Degree
Case Western Reserve University Undergraduate Degree
Stanford University School of Medicine Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Mark Chao in detail bekijken

Connecties

100 +

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
GILEAD SCIENCES, INC.

Health Technology

Bedrijven in privébezit7

Health Technology

Finance

Technology Services

Foresite Labs LLC

Health Technology

Health Technology

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Mark Chao